GROWTH-RESPONSE TO GROWTH-HORMONE (GH) TREATMENT RELATES TO SERUM INSULIN-LIKE-GROWTH-FACTOR-I (IGF-I) AND IGF-BINDING PROTEIN-3 IN SHORT CHILDREN WITH VARIOUS GH SECRETION CAPACITIES

Citation
B. Kristrom et al., GROWTH-RESPONSE TO GROWTH-HORMONE (GH) TREATMENT RELATES TO SERUM INSULIN-LIKE-GROWTH-FACTOR-I (IGF-I) AND IGF-BINDING PROTEIN-3 IN SHORT CHILDREN WITH VARIOUS GH SECRETION CAPACITIES, The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 2889-2898
Citations number
34
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
82
Issue
9
Year of publication
1997
Pages
2889 - 2898
Database
ISI
SICI code
0021-972X(1997)82:9<2889:GTG(TR>2.0.ZU;2-9
Abstract
The purpose of the study was to evaluate the relationship between the l-yr (n = 193) and 2-yr (n = 128) growth response and the individual s erum concentrations of insulin-like growth factor I(ICF-I) and IGF-bin ding protein 3 (IGFBP-3) before and during GK treatment. Our study gro up of prepubertal short children had from very low to high GH secretor y capacity, estimated during an arginine-insulin tolerance test, and t he ages ranged from 3-15 yr at the start of treatment. Their serum lev els of IGF-I and IGFBP-3 were low before treatment compared to those i n an age-related reference group of prepubertal children and increased significantly from the start to 1 month of GH treatment. The mean inc rease in height so score was 0.80 so score after 1 yr of GH treatment and 1.26 sn score after 2 yr, with a wide range. In univariate analyse s the highest correlation coefficients to the 2-yr growth response wer e found to be us. the following variables from the start of treatment: IGF-I so score (r = -0.49), log maximum GH concentration (log GH(max) ) during the arginine-insulin tolerance test (r = -0.47), difference b etween the height so score of the individual child and the midparental height sn score (diffSD score; r = -0.45), IGFBP-3 so score (r = -0.3 9), age (r = -0.30), short term change in IGFBP-3 so score (r = 0.37), and IGF-I so score (r = 0.34). In multivariate stepwise regression an alysis, 41% of the variation in the 2-yr growth response could be expl ained by IGF-I so score or log GH(max) together with age at the start of treatment, weight sn score at 1 yr of age, and diffSD score. When b oth IGF-I so score and GH(max) were included and when the short term c hanges in IGF-I so score were added, 46% and 58% of the variation, res pectively, could be explained. The regression algorithms using differe nt combinations of variables and their corresponding prediction interv als are also presented.